Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank90
3Y CAGR+128.7%
5Y CAGR-1.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+128.7%/yr
vs -40.9%/yr prior
5Y CAGR
-1.9%/yr
Recent acceleration
Acceleration
+169.7pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $310.87M | +181.2% |
| 2024 | $110.55M | +20.8% |
| 2023 | $91.54M | +252.4% |
| 2022 | $25.98M | -89.5% |
| 2021 | $247.79M | -27.4% |
| 2020 | $341.38M | +125.8% |
| 2019 | $151.20M | -29.1% |
| 2018 | $213.39M | +187.7% |
| 2017 | $74.17M | +171.0% |
| 2016 | $27.37M | - |